CD4 and ductal breast carcinoma in situ: The findings of Kim et al. [4] concerning the analysis of a small group of primary DCIS and its ipsilateral breast recurrence were in agreement with our observations as regards CD4+, CD8+, and it seems that only such a type of comparison should be performed to study the relationship between immune cells subsets during disease progression.